Literature DB >> 19213780

Superoxide dismutases, lung function and bronchial responsiveness in a general population.

M Siedlinski1, C C van Diemen, D S Postma, J M Vonk, H M Boezen.   

Abstract

Oxidative stress is an important causative factor in the onset and progression of smoking-related lung diseases, such as chronic obstructive pulmonary disease (COPD). Superoxide dismutases (SODs) can prevent an increase in oxidative burden. A total of 1,390 subjects from the prospective Vlagtwedde-Vlaardingen cohort were genotyped for two single nucleotide polymorphisms (SNPs) in SOD2 and four SNPs in SOD3, which were further analysed for associations with the presence of bronchial hyperresponsiveness (BHR; provocative concentration causing a 10% fall in the forced expiratory volume in one second (FEV(1); PC(10) <or=8 mg mL(-1) of histamine), COPD (defined as Global Initiative for Chronic Obstructive Lung Disease stage II or higher), lung function level and the longitudinal course of FEV(1). The intronic C5774T SNP of SOD2 was significantly associated with the presence of COPD and BHR in the total population. The T/T genotype for this polymorphism and the Val/Val genotype for the SOD2 Ala16Val substitution were risk factors for BHR in individuals without COPD. The SOD3 Arg213Gly substitution was associated with slower FEV(1) decline in never-smokers exclusively, and the SOD3 G(-4466)T SNP was associated with a lower vital capacity level. Both SOD2 polymorphisms are associated with bronchial hyperresponsiveness, a risk factor for chronic obstructive pulmonary disease, while SOD2 C5774T additionally confers a risk for chronic obstructive pulmonary disease in the total population. The current authors furthermore confirm previously reported associations of SOD3 single nucleotide polymorphisms with lung function in the general population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19213780     DOI: 10.1183/09031936.00171507

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  20 in total

1.  Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD.

Authors:  I C Sørheim; D L DeMeo; G Washko; A Litonjua; D Sparrow; R Bowler; P Bakke; S G Pillai; H O Coxson; D A Lomas; E K Silverman; C P Hersh
Journal:  COPD       Date:  2010-08       Impact factor: 2.409

2.  A time-varying group sparse additive model for genome-wide association studies of dynamic complex traits.

Authors:  Micol Marchetti-Bowick; Junming Yin; Judie A Howrylak; Eric P Xing
Journal:  Bioinformatics       Date:  2016-06-13       Impact factor: 6.937

3.  Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Grace E Kissling; Kara Fluharty; Denyse Gautrin; Jean-Luc Malo; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Dori R Germolec; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  Toxicol Sci       Date:  2012-05-17       Impact factor: 4.849

4.  Allele-specific effects of ecSOD on asbestos-induced fibroproliferative lung disease in mice.

Authors:  Sujung Jun; Cheryl L Fattman; Byung-Jin Kim; Harlan Jones; Ladislav Dory
Journal:  Free Radic Biol Med       Date:  2011-03-12       Impact factor: 7.376

Review 5.  Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases.

Authors:  Nguyen Hoai Nguyen; Gia-Buu Tran; Cuong Thach Nguyen
Journal:  J Mol Med (Berl)       Date:  2019-11-13       Impact factor: 4.599

6.  Secreted phosphoprotein 1 is a determinant of lung function development in mice.

Authors:  Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 7.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419

Review 8.  Biomarkers in Occupational Asthma.

Authors:  Javier Dominguez-Ortega; Pilar Barranco; Rosa Rodríguez-Pérez; Santiago Quirce
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

9.  Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung function.

Authors:  Wenbo Tang; Amy R Bentley; Stephen B Kritchevsky; Tamara B Harris; Anne B Newman; Douglas C Bauer; Bernd Meibohm; Patricia A Cassano
Journal:  Free Radic Biol Med       Date:  2013-05-17       Impact factor: 7.376

10.  A common polymorphism in extracellular superoxide dismutase affects cardiopulmonary disease risk by altering protein distribution.

Authors:  John M Hartney; Timothy Stidham; David A Goldstrohm; Rebecca E Oberley-Deegan; Michael R Weaver; Zuzana Valnickova-Hansen; Carsten Scavenius; Richard K P Benninger; Katelyn F Leahy; Richard Johnson; Fabienne Gally; Beata Kosmider; Angela K Zimmermann; Jan J Enghild; Eva Nozik-Grayck; Russell P Bowler
Journal:  Circ Cardiovasc Genet       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.